Try our beta test site
79 studies found for:    vaccine[TREATMENT] AND lymphoma NOT myeloma [ALL-FIELDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Immunotherapy for Asymptomatic Phase Lymphoplasmacytic Lymphoma
Conditions: Lymphoma;   Lymphoplasmacytic Lymphoma;   Waldenström Macroglobulinemia
Intervention: Biological: DNA Vaccine
2 Recruiting Idiotypic Vaccination for Follicular Lymphoma Patients
Conditions: Follicular Lymphoma;   First Relapse/Progression
Intervention: Biological: Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
3 Active, not recruiting Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention: Biological: Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells
4 Not yet recruiting Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention: Biological: Oncoquest-L vaccine
5 Completed Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Biological: Trivalent Baculovirus-expressed Influenza HA vaccine
6 Completed Autologous Vaccine for Follicular Lymphoma
Condition: Lymphoma, Follicular
Intervention: Biological: Autologous FL vaccine
7 Completed Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: plasmid DNA vaccine therapy;   Other: flow cytometry;   Other: immunoenzyme technique
8 Active, not recruiting Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma;   Lymphoma, Mantle Cell
Interventions: Drug: EPOCH-R;   Biological: GM-CSF;   Drug: Idiotype vaccine
9 Completed Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma
Condition: Influenza
Interventions: Biological: Trivalent inactivated influenza vaccine;   Biological: Trivalent Baculovirus-expressed Influenza HA vaccine
10 Completed Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab
Condition: Non-Hodgkin Lymphoma (NHL)
Intervention: Biological: influenza vaccination with influenza vaccine
11 Terminated Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: Hodgkin's antigens-GM-CSF-expressing cell vaccine;   Procedure: adjuvant therapy
12 Withdrawn Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
Conditions: Hodgkin Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Biological: LMP2A-loaded conventional DC vaccine;   Biological: DUK-CPG-001
13 Active, not recruiting
Has Results
Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Dexamethasone;   Biological: Autologous Tumor Cell-Based Vaccine;   Drug: IL-2
14 Completed Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
Conditions: B Cell Lymphoma;   Follicular Lymphoma;   Lymphoma
Interventions: Drug: Id-KLH Vaccine;   Drug: GM-CSF
15 Active, not recruiting Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Condition: Lymphoma, Mantle-Cell
Interventions: Biological: CpG-MCL vaccine, primed T-cells;   Procedure: Autologous peripheral blood stem cell transplantation;   Procedure: CT scan;   Procedure: PET-CT scan;   Drug: PF-3512676;   Drug: Rituximab
16 Terminated
Has Results
Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: autologous tumor cell vaccine;   Biological: keyhole limpet hemocyanin;   Biological: sargramostim;   Procedure: adjuvant therapy
17 Completed Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention: Biological: Radiotherapy, rituximab and DC
18 Completed Idiotype Vaccine Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Patients With Lymphoma Who Had Failed Induction Chemotherapy
Condition: Lymphoma
Intervention: Biological: Id-KLH
19 Completed Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma
Condition: Lymphoma
Interventions: Biological: aldesleukin;   Biological: autologous tumor cell vaccine
20 Completed Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
Conditions: B Cell Lymphoma;   Follicular Lymphoma;   Neoplasm
Interventions: Drug: Id-KLH Vaccine;   Drug: QS-21 (Stimulation-QS-21) Drug

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.